The first-ever reverse-aging drug was just injected into a human
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.
Business Insider Mkt — 9 June 2026
Text:
8
0
0
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.
This report comes from Business Insider Mkt. The story centres on The first-ever reverse-aging drug was just injected into a human. Full coverage and background context is available at the original source. Readers seeking more detail on this developing topic are encouraged to follow updates from Business Insider Mkt and related outlets covering this beat.
Sources
📈 Markets & Finance
Sam Altman says OpenAI's top token spender uses 100 billion tokens a month — and they're not even the world leader
📈 Markets & Finance
Intel, AMD, Micron shares sink as Broadcom results spark semiconductor sector sell-off
📈 Markets & Finance
This Smart‑Money Legend Won Big on Intel. The Rest of His Portfolio Might Be Even More Revealing
📈 Markets & Finance
MGM Resorts stock jumps as Barry Diller's People Inc. makes bid to take over the company
📈 Markets & Finance
A new NJ bill would hand pet owners up to $900 in tax credits — and your state could be next
📈 Markets & Finance
Addressing Investor Transparency, Updates from Euronet Worldwide’s (EEFT) First Analyst Day in a Decade
